Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned...
-
– Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from...
-
VERNON, CA, March 13, 2024 (GLOBE NEWSWIRE) -- AXIS IOS, a real estate investment platform dynamically positioned to acquire, develop, and manage Industrial Outdoor Storage (“IOS”) throughout the...
-
Press Release Paris, 7 March 2024 Full Year 2023 Results RECORD FINANCIAL PERFORMANCE IN 2023 CAPTURING GROWTH IN ALL BUSINESSES &EXPANSION INTO LIVE EXPERIENCES THROUGH M&A CONFIDENT FOR...
-
Highlights: Immuron proceeding to Phase 3 registration strategy with the FDATravelan® topline clinical trial results demonstrate protective efficacy with single daily dose36.4% protective efficacy...
-
Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders’ meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and...
-
Fort Collins, Colorado, March 01, 2024 (GLOBE NEWSWIRE) -- The Automotive Artificial Intelligence Market size valued at USD 3.1 Billion in 2023 and is anticipated to reach USD 23.8 Billion by 2032...
-
NEWARK, Del, Feb. 29, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights (FMI), the DC drive market had an estimated market size of US$ 5.5 Billion in 2023 and is expected to reach a...
-
2023年第四季度经调整EBITDA为28亿元对比2022年第四季度为(1.63)亿元 2023年全年经调整EBITDA为100亿元，对比2022年为(6)亿元 集团全年股东应占溢利为68亿元，对比2022年为(34)亿元 宣布派发另一次特别股息每股0.30元 香港, Feb. 28, 2024 (GLOBE NEWSWIRE) --...
-
Q4 2023 Group Adjusted EBITDA of $2.8 Billion,Versus $(163) Million in Q4 2022 2023 Full Year Group Adjusted EBITDA of $10.0 Billion Versus $(0.6) Billion in 2022 2023 Full Year Group NPAS of $6.8...